106 related articles for article (PubMed ID: 6547748)
21. Diethylstilbestrol di-trimethylacetate (DSTMA). A long-acting estrogen.
Noland JL; Amin M
Invest Urol; 1980 May; 17(6):506-9. PubMed ID: 7372439
[TBL] [Abstract][Full Text] [Related]
22. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia.
Knauf WU; Lissichkov T; Aldaoud A; Liberati A; Loscertales J; Herbrecht R; Juliusson G; Postner G; Gercheva L; Goranov S; Becker M; Fricke HJ; Huguet F; Del Giudice I; Klein P; Tremmel L; Merkle K; Montillo M
J Clin Oncol; 2009 Sep; 27(26):4378-84. PubMed ID: 19652068
[TBL] [Abstract][Full Text] [Related]
23. A phase II multicenter, randomized, double-blind, safety trial assessing the pharmacokinetics, pharmacodynamics, and efficacy of oral 2-methoxyestradiol capsules in hormone-refractory prostate cancer.
Sweeney C; Liu G; Yiannoutsos C; Kolesar J; Horvath D; Staab MJ; Fife K; Armstrong V; Treston A; Sidor C; Wilding G
Clin Cancer Res; 2005 Sep; 11(18):6625-33. PubMed ID: 16166441
[TBL] [Abstract][Full Text] [Related]
24. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
Murren J; Modiano M; Clairmont C; Lambert P; Savaraj N; Doyle T; Sznol M
Clin Cancer Res; 2003 Sep; 9(11):4092-100. PubMed ID: 14519631
[TBL] [Abstract][Full Text] [Related]
25. [Clinical evaluation of flutamide, a pure antiandrogen, in prostatic cancer phase II dose-finding study].
Aso Y; Akaza H; Koiso K; Kameyama S; Koyanagi T; Kawai T; Kumamoto Y; Tazaki H; Funyu T; Oshima H
Hinyokika Kiyo; 1993 Apr; 39(4):391-403. PubMed ID: 8503339
[TBL] [Abstract][Full Text] [Related]
26. [An experimental study of cancer therapy through the augmented foreign body reaction].
Kanemura M
Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):56-66. PubMed ID: 3288702
[No Abstract] [Full Text] [Related]
27. High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma.
Morris MJ; Smaletz O; Solit D; Kelly WK; Slovin S; Flombaum C; Curley T; Delacruz A; Schwartz L; Fleisher M; Zhu A; Diani M; Fallon M; Scher HI
Cancer; 2004 May; 100(9):1868-75. PubMed ID: 15112267
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.
Smith DC; Chay CH; Dunn RL; Fardig J; Esper P; Olson K; Pienta KJ
Cancer; 2003 Jul; 98(2):269-76. PubMed ID: 12872344
[TBL] [Abstract][Full Text] [Related]
29. Tamoxifen for flutamide/finasteride-induced gynecomastia.
Staiman VR; Lowe FC
Urology; 1997 Dec; 50(6):929-33. PubMed ID: 9426725
[TBL] [Abstract][Full Text] [Related]
30. Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases.
Koutsilieris M; Mitsiades CS; Bogdanos J; Dimopoulos T; Karamanolakis D; Milathianakis C; Tsintavis A
Clin Cancer Res; 2004 Jul; 10(13):4398-405. PubMed ID: 15240528
[TBL] [Abstract][Full Text] [Related]
31. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
32. [Phase I study of flutamide, a nonsteroidal antiandrogen, in patients with prostatic cancer].
Aso Y; Akaza H; Koiso K; Kumamoto Y; Kawai T; Origasa S; Hosaka M; Yamanaka H; Shimazaki J; Fuse H
Hinyokika Kiyo; 1993 Apr; 39(4):381-9. PubMed ID: 8503338
[TBL] [Abstract][Full Text] [Related]
33. Radiosensitization and modulation of p44/42 mitogen-activated protein kinase by 2-Methoxyestradiol in prostate cancer models.
Casarez EV; Dunlap-Brown ME; Conaway MR; Amorino GP
Cancer Res; 2007 Sep; 67(17):8316-24. PubMed ID: 17804747
[TBL] [Abstract][Full Text] [Related]
34. [Studies on mechanisms of the action of androgens on prostate. 2. Inhibitory effect of estrogen on 5 -reductase and application of estradiol-17 diphosphate to treatment of prostatic cancer].
Shida K; Shimazaki J; Urano E; Kurihara H; Takahashi H
Nihon Hinyokika Gakkai Zasshi; 1972 Jan; 63(1):27-42. PubMed ID: 5062566
[No Abstract] [Full Text] [Related]
35. Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma.
Bhandari MS; Pienta KJ; Fardig J; Olson K; Smith DC
Cancer; 2006 Apr; 106(8):1715-21. PubMed ID: 16534795
[TBL] [Abstract][Full Text] [Related]
36. Oral topotecan given once or twice daily for ten days: a phase I pharmacology study in adult patients with solid tumors.
Gerrits CJ; Burris H; Schellens JH; Eckardt JR; Planting AS; van der Burg ME; Rodriguez GI; Loos WJ; van Beurden V; Hudson I; Fields S; Von Hoff DD; Verweij J
Clin Cancer Res; 1998 May; 4(5):1153-8. PubMed ID: 9607572
[TBL] [Abstract][Full Text] [Related]
37. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of advanced prostatic carcinoma with ketoconazole. Our experience in 10 cases].
Clar Blanch F; Galan Brotons A; Chuan Nuez P; Gil Salom M; Santamaría Meseguer J; Carretero González P
Actas Urol Esp; 1989; 13(2):82-4. PubMed ID: 2728946
[TBL] [Abstract][Full Text] [Related]
39. A phase I trial of weekly paclitaxel, 13- cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies.
Thalasila A; Poplin E; Shih J; Dvorzhinski D; Capanna T; Doyle-Lindrud S; Beers S; Goodin S; Rubin E; DiPaola RS
Cancer Chemother Pharmacol; 2003 Aug; 52(2):119-24. PubMed ID: 12768320
[TBL] [Abstract][Full Text] [Related]
40. re: Comparison of primary orchiectomy and polyoestradiol phosphate in the treatment of advanced prostatic cancer. R. Haapiainen et al. Br. J. Urol., 66, 94-97, 1990.
Bishop MC
Br J Urol; 1991 Aug; 68(2):218. PubMed ID: 1884161
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
